Characterizing Sleep Disorders in Children and Adults With Tuberous Sclerosis Complex (TSC)
Primary Purpose
Sleep Disorder
Status
Unknown status
Phase
Not Applicable
Locations
Belgium
Study Type
Interventional
Intervention
Questionnaires
electroencephalogram (EEG)
polysomnography
Actigraphy
Sponsored by
About this trial
This is an interventional other trial for Sleep Disorder focused on measuring tuberous sclerosis complex (TSC), Children, Adults
Eligibility Criteria
Inclusion Criteria:
Children and adults with definite TSC based on the 2012 Consensus Conference Diagnostic
Exclusion Criteria:
- daily alcohol intake
- pregnancy
- caffeine abuse (>4 cups/day)
- shift work
- drug abuse
- anti-depressive therapy
- medications as benzodiazepine, melatonin, phenobarbital and antihistamines
- the presence of clinical or electrographic seizures.
Sites / Locations
- Universitair Ziekenhuis BrusselRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Other
Other
Arm Label
Children
Adults
Arm Description
Questionnaires electroencephalogram (EEG) Actigraphy polysomnography
Questionnaires electroencephalogram (EEG) Actigraphy polysomnography
Outcomes
Primary Outcome Measures
characterize the sleep phenotype of TSC in children and adults without epilepsy
- Sleep efficiency (SE%): the percentage ratio between total sleep time and time in bed (TST/TIB*100)
Secondary Outcome Measures
Full Information
NCT ID
NCT03326765
First Posted
October 6, 2017
Last Updated
October 15, 2018
Sponsor
Universitair Ziekenhuis Brussel
1. Study Identification
Unique Protocol Identification Number
NCT03326765
Brief Title
Characterizing Sleep Disorders in Children and Adults With Tuberous Sclerosis Complex (TSC)
Official Title
Characterizing Sleep Disorders in Children and Adults With Tuberous Sclerosis Complex (TSC)
Study Type
Interventional
2. Study Status
Record Verification Date
October 2018
Overall Recruitment Status
Unknown status
Study Start Date
September 27, 2017 (Actual)
Primary Completion Date
November 1, 2019 (Anticipated)
Study Completion Date
November 30, 2019 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Universitair Ziekenhuis Brussel
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
The proposed research project is aimed at further characterization of sleep problems and evaluation of their impact in children and adults with TSC, excluding epilepsy as contributing factor. Questionnaire-based studies have shown that sleep problems occur in up to half of the children and a third of adults with tuberous sclerosis complex (TSC). However, there is only limited information on the nature of sleep problems and their impact on patients with TSC and their families.
Detailed Description
Questionnaire-based studies have shown that sleep problems occur in up to half of the children and a third of adults with tuberous sclerosis complex (TSC). However, there is only limited information on the nature of sleep problems and their impact on patients with TSC and their families. It is known from a questionnaire-based study in children with TSC that they often wake early or wake frequently during the night, and that they can be more tired during the day. In some children, sleep-problems seem to be related to the presence of seizures during the night. This has been confirmed in a study on 10 children with TSC and epilepsy by a combination of polysomnography (sleep study) and electroencephalography (EEG). A questionnaire-based study in adults also revealed the association with epilepsy features, and showed influence of mental health complaints on sleep.
Sleep structure and quality will be assessed through formal sleep studies (polysomnography and actigraphy). The influence of abnormal brain activity on sleep will be mapped by simultaneous recording of brain activity by means of EEG. The impact of sleep disorders will be determined through interviews with individuals with TSC and their relatives. The investigators will also use questionnaires and diaries to supplement their findings.
Importance: It is expected that the results of this study will 1) improve our understanding of sleep problems in TSC, 2) provide additional information on the influence of TSC on sleep, 3) give a more in-depth view on the impact of sleep problems on the lives of individuals with TSC and their families, 4) increase awareness about sleep problems in TSC, and 5) contribute to a better management of sleep problems by patients and families.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sleep Disorder
Keywords
tuberous sclerosis complex (TSC), Children, Adults
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
2 groups:
30 Children(0-18y) withTSC without epilepsy
30 Adults(>18y) withTSC without epilepsy
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
60 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Children
Arm Type
Other
Arm Description
Questionnaires electroencephalogram (EEG) Actigraphy polysomnography
Arm Title
Adults
Arm Type
Other
Arm Description
Questionnaires electroencephalogram (EEG) Actigraphy polysomnography
Intervention Type
Other
Intervention Name(s)
Questionnaires
Intervention Description
Epworth sleepiness scale
Pittsburgh sleep quality Index (PSQI)
EQ-5D Adults
Pediatric Daytime Sleepiness scale (PDSS)
Sleep disturbance Scale for Children (SDSC
EQ-5D Children
Sleaping diary
Intervention Type
Procedure
Intervention Name(s)
electroencephalogram (EEG)
Intervention Description
is an electrophysiological monitoring method to record electrical activity of the brain
Intervention Type
Procedure
Intervention Name(s)
polysomnography
Intervention Description
type of sleep study, is a multi-parametric test used in the study of sleep and as a diagnostic tool in sleep medicine
Intervention Type
Procedure
Intervention Name(s)
Actigraphy
Intervention Description
type of sleep study based on bracelet around the wrist
Primary Outcome Measure Information:
Title
characterize the sleep phenotype of TSC in children and adults without epilepsy
Description
- Sleep efficiency (SE%): the percentage ratio between total sleep time and time in bed (TST/TIB*100)
Time Frame
1 night
10. Eligibility
Sex
All
Minimum Age & Unit of Time
1 Day
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Children and adults with definite TSC based on the 2012 Consensus Conference Diagnostic
Exclusion Criteria:
daily alcohol intake
pregnancy
caffeine abuse (>4 cups/day)
shift work
drug abuse
anti-depressive therapy
medications as benzodiazepine, melatonin, phenobarbital and antihistamines
the presence of clinical or electrographic seizures.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Veerle Van Mossevelde, Study coordinator
Phone
+3224763134
Email
veerle.vanmossevelde@uzbrussel.be
First Name & Middle Initial & Last Name or Official Title & Degree
Dirk De Clippeleir, Study coordinator
Phone
+3224763580
Email
dirk.declippeleir@uzbrussel.be
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Anna Jansen, PhD, MD
Organizational Affiliation
Universitair Ziekenhuis Brussel
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Sonia De Weerdt, MD
Organizational Affiliation
Universitair Ziekenhuis Brussel
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Alessandra Pereira,, PhD, MD
Organizational Affiliation
Department of Pediatrics School of Medicine, PUCRS, Brazil
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Magda Nunes, PhD, MD
Organizational Affiliation
Director, School of Medicine, PUCRS, Brazil; Brain Instititute of Rio Grande do Sul, Brazil
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Oliviero Bruni, PhD, MD
Organizational Affiliation
Department of Developmental and Social Psychology, Sapienza University of Rome, Italy
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Paolo Curatolo, PhD, MD
Organizational Affiliation
Director, Child Neurology and Psychiatry Unit, Systems Medicine Department, Tor Vergata University of Rome, Italy
Official's Role
Principal Investigator
Facility Information:
Facility Name
Universitair Ziekenhuis Brussel
City
Jette
State/Province
Vlaams Brabant
ZIP/Postal Code
1090
Country
Belgium
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Veerle Van Mossevelde, Datanurse
Phone
+3224763134
Email
veerle.vanmossevelde@uzbrussel.be
12. IPD Sharing Statement
Learn more about this trial
Characterizing Sleep Disorders in Children and Adults With Tuberous Sclerosis Complex (TSC)
We'll reach out to this number within 24 hrs